USMLE Hematology-Oncology: Leukemias (ALL, AML, CLL, CML) – Age, Markers, Philadelphia

What This Is and Why It Matters for USMLE

Leukemias: ALL, AML, CLL, CML are high-yield topics for Step 1 and Step 2 CK, with a moderate presence in Step 3. These malignancies are crucial for understanding hematologic disorders, which are frequently tested on the USMLE.

High-Yield Facts (What You Must Memorize)

• Pathophysiology (Step 1):
  • ALL: acute lymphoblastic leukemia, often in children, with thymic involvement and lymphadenopathy.
  • AML: acute myeloid leukemia, often in adults, with bone marrow failure and bleeding.
  • CLL: chronic lymphocytic leukemia, often in older adults, with lymphadenopathy and splenomegaly.
  • CML: chronic myeloid leukemia, often in adults, with leukocytosis and splenomegaly.
• Classic presentation and physical exam findings (Step 2 CK):
  • ALL: petechiae, bruising, lymphadenopathy.
  • AML: bone pain, bleeding, petechiae.
  • CLL: lymphadenopathy, splenomegaly, fatigue.
  • CML: leukocytosis, splenomegaly, bone pain.
• Diagnostic approach (labs, imaging):
  • CBC, blast percentage, bone marrow biopsy.
  • Imaging: CT scans, PET scans, MRI.
• First-line treatment and management (Step 2 CK, Step 3):
  • ALL: chemotherapy, stem cell transplant.
  • AML: chemotherapy, stem cell transplant.
  • CLL: chemotherapy, targeted therapy.
  • CML: targeted therapy, chemotherapy.
• Red flags, complications, and follow-up:
  • ALL: infection, bleeding, central nervous system involvement.
  • AML: infection, bleeding, bone marrow failure.
  • CLL: infection, splenic rupture, lymphoma progression.
  • CML: infection, bleeding, resistance to therapy.

Clinical Pearls & Buzzwords

• Philadelphia chromosome (BCR-ABL fusion) in CML.
• CD20 in CLL.
• CD33 in AML.
• CD19 in ALL.
• Blast percentage in ALL and AML.

Step-by-Step Clinical Reasoning

1. Identify the syndrome or presentation: Leukemia, lymphadenopathy, splenomegaly.
2. Generate a differential (most likely and must-not-miss):
   • ALL: lymphoma, leukemia.
   • AML: lymphoma, leukemia, myelodysplastic syndrome.
   • CLL: lymphoma, leukemia, lymphoproliferative disorder.
   • CML: lymphoma, leukemia, myeloproliferative disorder.
3. Order appropriate initial tests: CBC, blast percentage, bone marrow biopsy.
4. Interpret results: Blast percentage, bone marrow biopsy, cytogenetics.
5. Initiate treatment and monitoring: Chemotherapy, targeted therapy, stem cell transplant.

Common Mistakes & Exam Traps

• The mistake: Failing to consider blast percentage in ALL and AML.
• Why it happens: Rushing through the question or misreading the lab values.
• How to avoid it: Double-check the lab values and consider the blast percentage in your differential diagnosis.
• Exam board insight: The examiners will penalize you for not considering the blast percentage in ALL and AML.
• The mistake: Not considering Philadelphia chromosome in CML.
• Why it happens: Misunderstanding the importance of cytogenetics in CML.
• How to avoid it: Remember that Philadelphia chromosome is a hallmark of CML.
• Exam board insight: The examiners will reward you for considering the Philadelphia chromosome in CML.

How It’s Tested on USMLE

• Step 1: Basic science vignette (e.g., molecular mechanism, pathology slide, pharmacology).
• Step 2 CK: Clinical vignette (e.g., "A 45-year-old with chest pain..."). Focus on next step in diagnosis or treatment.
• Step 3: Similar to Step 2 CK, plus prognosis, risk factors, and occasionally CCS management.
• Common distractors: Lymphoma, leukemia, myeloproliferative disorder.

CCS (Step 3) Relevance (If Applicable)

• Initial orders: CBC, blast percentage, bone marrow biopsy.
• Monitoring and follow-up: Chemotherapy, targeted therapy, stem cell transplant.
• Common mistakes: Not ordering blast percentage or bone marrow biopsy.

Practice Questions (3-5 single-best-answer)

Question 1: A 25-year-old with ALL presents with petechiae, bruising, and lymphadenopathy. Which of the following is the most likely diagnosis? A) Lymphoma B) Leukemia C) Myeloproliferative disorder D) Lymphoproliferative disorder Answer: B) Leukemia Explanation: The patient's presentation of petechiae, bruising, and lymphadenopathy is classic for ALL.

Question 2: A 60-year-old with CLL presents with lymphadenopathy, splenomegaly, and fatigue. Which of the following is the most likely diagnosis? A) Lymphoma B) Leukemia C) Lymphoproliferative disorder D) Myeloproliferative disorder Answer: B) Leukemia Explanation: The patient's presentation of lymphadenopathy, splenomegaly, and fatigue is classic for CLL.

Question 3: A 30-year-old with CML presents with leukocytosis, splenomegaly, and bone pain. Which of the following is the most likely diagnosis? A) Lymphoma B) Leukemia C) Myeloproliferative disorder D) Lymphoproliferative disorder Answer: B) Leukemia Explanation: The patient's presentation of leukocytosis, splenomegaly, and bone pain is classic for CML.

Quick Reference Card (60-Second Summary)

• ALL: Blast percentage, bone marrow biopsy, chemotherapy.
• AML: Blast percentage, bone marrow biopsy, chemotherapy.
• CLL: CD20, lymphadenopathy, splenomegaly.
• CML: Philadelphia chromosome, leukocytosis, splenomegaly.

If You Get Stuck on Test Day

• Eliminate obviously wrong answers: Look for red flags in the patient's presentation.
• Use the "next best step" hierarchy: Consider the patient's blast percentage, bone marrow biopsy, and cytogenetics.
• For Step 3 CCS: Order basic labs, vitals, and IV access when unsure.

Related USMLE Topics

• Lymphoma: Connects to ALL, CLL, and CML through lymphadenopathy and splenomegaly.
• Myeloproliferative disorder: Connects to CML through leukocytosis and splenomegaly.
• Myelodysplastic syndrome: Connects to AML through bone marrow failure and bleeding.